MedTrace Logo

The Effect of Buteyko Breathing Technique on Asthma Patients

NCT07353242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-01-20

No results posted yet for this study

Summary

This study was designed as a pre-test-post-test randomized controlled experimental trial to determine the effects of buteyko breathing technique application on fatigue, exercise capacity, and asthma control in asthma patients.The study, planned as a randomized controlled experimental study, included a total of 90 participants.

The sample consisted of asthma patients who applied to the Chest Diseases outpatient clinic of Gaziantep University Application and Research Hospital, had been diagnosed with asthma within the last 6 months, did not have heart failure, did not have communication or perception problems, did not have walking disabilities, and were between 18-59 years old.Following random assignment, participants were divided into two groups of 45 participants each. The groups were: 1) Buteyko 2) Control

Conditions

Interventions

OTHER

Buteyko Breathing Technique

This intervention is distinguished by its standardized delivery by an internationally certified Buteyko practitioner and its integration of key Buteyko components, including reduced breathing, controlled breath-holding, nasal breathing with mouth taping, and relaxation. It incorporates both seated and walking-based exercises, uses objective measures such as Control Pause and step counting, and includes a structured home-based practice with weekly follow-up over six weeks.

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Adile Neşe · University of Gaziantep

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2025-06-25
Completion
2025-07-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07353242 on ClinicalTrials.gov